BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 6954340)

  • 1. [Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Meschengieser SS; Woods AI; Schattner MA; Lazzari MA
    Medicina (B Aires); 1981; 41 Suppl():267-73. PubMed ID: 6954340
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metamorphosis of chronic myeloproliferative diseases].
    Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
    Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
    Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
    [No Abstract]   [Full Text] [Related]  

  • 4. Abnormalities of platelet function in the myeloproliferative disorders.
    Cardamone JM; Edson JR; McArthur JR; Jacob HS
    JAMA; 1972 Jul; 221(3):270-3. PubMed ID: 4504007
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical Grand Rounds--chronic granulocytic leukemia with thrombocytosis; the hypercoagulability states.
    Kossmann CE; Hubbard WS; Chesney CM
    J Tenn Med Assoc; 1981 Oct; 74(10):742-3, 745. PubMed ID: 6947124
    [No Abstract]   [Full Text] [Related]  

  • 8. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
    Kessler CM; Klein HG; Havlik RJ
    Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic dilemmas: balancing the risks of bleeding, thrombosis, and leukemic transformation in myeloproliferative disorders (MPD).
    Murphy S
    Thromb Haemost; 1997 Jul; 78(1):622-6. PubMed ID: 9198227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
    Murphy S; Davis JL; Walsh PN; Gardner FH
    Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.
    Preston FE; Martin JF; Stewart RM; Davies-Jones GA
    Br Med J; 1979 Dec; 2(6204):1561-3. PubMed ID: 534868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism--thesis, Rotterdam, 1981.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):335-8. PubMed ID: 9263349
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet function in chronic myeloproliferative syndromes associated with thrombocytosis].
    Grebe G; Pereira J; Mezzano D; Legues ME; Aranda E; Lira P
    Rev Med Chil; 1985 Jan; 113(1):32-7. PubMed ID: 4081383
    [No Abstract]   [Full Text] [Related]  

  • 14. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
    Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
    Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelets in the myeloproliferative syndrome.
    Weinfeld A; Branehög I; Kutti J
    Clin Haematol; 1975 Jun; 4(2):373-92. PubMed ID: 1102193
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses].
    Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H
    Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet defects in chronic myeloproliferative disorders].
    Raszeja-Specht A; Skibowska A; Kabata J; Hellmann A
    Acta Haematol Pol; 1994; 25(3):253-60. PubMed ID: 7992598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
    van Genderen PJ; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemorrhagic thrombocythemia study of a case with personal observation].
    Tognella S; Mantovani G; Grifoni V
    Recenti Prog Med; 1976 Jul; 62(1):99-113. PubMed ID: 1070714
    [No Abstract]   [Full Text] [Related]  

  • 20. Bleeding and thrombosis in the myeloproliferative disorders.
    Schafer AI
    Blood; 1984 Jul; 64(1):1-12. PubMed ID: 6375757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.